Where does Merit Medical Systems's cash flow data come from?

Every line is extracted from Merit Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	$139.34M+8.4%	$128.49M+8.5%	$118.43M-0.6%	$119.12M-2.6%	$122.26M+1.6%
Depreciation and amortization	$124.37M+1.0%	$123.17M+2.4%	$120.25M+4.3%	$115.33M+6.4%	$108.4M+5.5%
Stock-based compensation	$43.34M-0.3%	$43.46M+0.9%	$43.08M+19.1%	$36.18M+12.0%	$32.32M+13.5%
Amortization of debt issuance costs	——	——	——	——	——
Impairment charges	$418K+33.5%	$313K+51.2%	$207K-19.8%	$258K-9.8%	$286K-37.3%
Gain (loss) on sale of assets	-$2.28M+0.9%	-$2.3M-26.4%	-$1.82M-5.5%	-$1.73M-11.9%	-$1.54M-3.5%
Change in accounts receivable	——	——	——	——	$17.06M+24.7%
Change in inventories	$33.66M+55.8%	$21.6M—	——	——	——
Change in accounts payable	——	——	——	——	——
Change in accrued liabilities	$1.74M-87.8%	$14.26M-6.0%	$15.18M—	——	——
Change in other assets	——	——	——	——	——
Change in other liabilities	——	——	——	——	——
Other working capital changes	$158.14M-6.4%	$168.88M+13.2%	$149.18M+23.5%	$120.84M+17.4%	$102.89M+2.4%
Change in income taxes payable/receivable	$11.15M+98.8%	$5.61M—	——	——	——
Net gains (losses) on investments	——	——	——	——	——
Non-cash operating lease expense	$11.35M-1.1%	$11.48M-1.6%	$11.67M-0.5%	$11.73M-1.3%	$11.89M-1.1%
Change in operating lease liabilities	-$10.6M+5.1%	-$11.17M+4.6%	-$11.71M+3.6%	-$12.15M+3.5%	-$12.59M-3.3%
Change in fair value of contingent consideration	——	——	$1.35M-5.0%	$1.42M-10.3%	$1.58M+257%
Change in receivables	——	——	——	$3.17M-49.5%	$6.27M-6.3%
Net cash from operating activities	$297.48M0.0%	$297.37M+11.1%	$267.61M+11.5%	$239.96M+6.6%	$225.16M+2.0%
Capital expenditures	$76.66M-6.2%	$81.72M+34.6%	$60.72M+27.5%	$47.64M+7.0%	$44.52M+26.7%
Acquisitions, net of cash acquired	$144.77M0.0%	$144.77M-56.5%	$332.83M-24.0%	$437.81M+37.6%	$318.18M-0.6%
Proceeds from sale of businesses	——	——	——	——	——
Purchases of intangible assets	$3.42M+9.6%	$3.12M+0.9%	$3.09M+17.9%	$2.62M+5.0%	$2.5M-13.9%
Net cash from investing activities	-$210.02M+15.1%	-$247.39M+39.9%	-$411.5M+18.2%	-$503.1M-33.7%	-$376.24M-2.1%
Proceeds from issuance of debt	——	——	——	——	——
Proceeds from issuance of common stock	$17.84M-36.8%	$28.21M-40.8%	$47.66M-4.7%	$49.99M+7.9%	$46.33M+13.3%
Other financing activities	$4.78M+77.8%	$2.69M-0.4%	$2.7M+0.4%	$2.69M+1,043%	$235K-10.0%
Net cash from financing activities	$3.12M-80.9%	$16.36M—	——	——	——
Effect of exchange rate changes on cash	$2.44M-35.9%	$3.8M+2,078%	-$192K-109%	$2.19M+942%	-$260K+89.7%
Net increase (decrease) in cash	$92.65M+32.8%	$69.78M+153%	-$130.72M+55.7%	-$294.8M-58.2%	-$186.39M+11.4%
Interest paid	——	——	$28.16M-13.0%	$32.37M-2.5%	$33.21M+42.9%
Income taxes paid	$31.99M+1.9%	$31.39M-11.1%	$35.32M-16.1%	$42.09M-10.0%	$46.77M+3.8%
Non-cash interest expense	——	——	——	——	——
Contingent consideration fair value adjustments	——	——	$1.35M-5.0%	$1.42M-10.3%	$1.58M+257%
Gain/(loss) on dispositions, net	-$2.28M+0.9%	-$2.3M-26.4%	-$1.82M-5.5%	-$1.73M-11.9%	-$1.54M-3.5%
Gain on sale of business and assets	$12.69M+4,996%	$249K—	——	——	——
Equity in earnings (losses) of equity method investees	——	——	——	——	——
Accounts payable	——	——	——	——	——
Increase Decrease In Deferred Compensation	——	——	-$2.11M-271%	$1.23M+201%	$410K-80.0%
Increase (Decrease) in Income Taxes Receivable	$1.71M+795%	-$246K—	——	——	——
Operating lease liabilities	-$10.6M+5.1%	-$11.17M+4.6%	-$11.71M+3.6%	-$12.15M+3.5%	-$12.59M-3.3%
Increase (Decrease) in Other Operating Assets	$2.38M+29.9%	$1.83M-54.7%	$4.04M-11.7%	$4.57M+38.7%	$3.3M-45.7%
Increase (Decrease) in Other Receivables	——	——	——	$3.17M-49.5%	$6.27M-6.3%
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——	——
Operating lease right-of-use asset amortization	$11.35M-1.1%	$11.48M-1.6%	$11.67M-0.5%	$11.73M-1.3%	$11.89M-1.1%
Payments to Acquire Intangible Assets	$3.42M+9.6%	$3.12M+0.9%	$3.09M+17.9%	$2.62M+5.0%	$2.5M-13.9%
Proceeds From Sale Of Property Plant And Equipment And Divestiture Of Businesses	——	$303K+32.6%	$228.5K+48.4%	$154K+93.7%	$79.5K+1,490%
Payments For Derivative Instrument Financing Activities	——	——	——	——	——
Payments Related To Tax Withholding For Exchange Of Common Stock	$10.31M+8.2%	$9.53M—	——	——	——
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations	$2.44M-35.9%	$3.8M+2,078%	-$192K-109%	$2.19M+942%	-$260K+89.7%
Leased assets obtained in exchange for operating lease liabilities	$9.6M-70.6%	$32.68M+3.7%	$31.51M+4.1%	$30.28M+11.9%	$27.06M+172%
Income Taxes Paid, Net	$31.99M+1.9%	$31.39M-11.1%	$35.32M-16.1%	$42.09M-10.0%	$46.77M+3.8%
Free cash flow	$220.82M+2.4%	$215.66M+4.2%	$206.88M+7.6%	$192.31M+6.5%	$180.64M-2.7%
Free cash flow	$220.82M+2.4%	$215.66M+4.2%	$206.88M+7.6%	$192.31M+6.5%	$180.64M-2.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Merit Medical Systems's cash flow data come from?: Every line is extracted from Merit Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.